Human Papillomavirus Infection Articles & Analysis
5 news found
Amerigo Scientific provides high-quality and cost-effective medical device products worldwide to advance human health and address health emergencies. Nowadays human papillomavirus (HPV) infection has been recognized as the prerequisite for most anogenital malignancies accounting for more than 90% of cervical and anal cancers, ...
(NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform, today announced positive Phase 1 results from its HB-200 program evaluating single-vector HB-201 and alternating 2-vector HB-202/HB-201 in advanced Human Papillomavirus 16-positive (HPV16+) head and neck cancer patients. ...
The programs include: A Phase 1/2 clinical trial of VTP-300 in patients with chronic hepatitis B virus (HBV) infection. The first patient in the trial was dosed in February 2021. A Phase 1/2 clinical trial of VTP-200 in patients with persistent, high-risk human papillomavirus (HPV) infection. A Phase 1/2 clinical trial of ...
This evaluation has proven the ability of IMX313P to enhance the efficacy of a DKFZ’ vaccine candidate indicated in the prevention of human papillomavirus (HPV) infections, a virus that can lead to cervical cancers. ...
It will be tested to enhance the efficacy of one of the Center’s candidate vaccines, which is indicated in the prevention of human papillomavirus (HPV) infections. Certain strains of this virus are implicated in cervical cancers. ...